Article Versions Notes

Talavera Guillén NC, Barboza de Nardi A, Noleto de Paiva F, Dias QC, Pinheiro Fantinatti A, Fávaro WJ. Clinical Implications of Immune Checkpoints and the RANK/RANK-L Signaling Pathway in High-Grade Canine Mast Cell Tumors. Animals. 2023; 13(12):1888. https://doi.org/10.3390/ani13121888

Talavera Guillén, Noelia C., Andrigo Barboza de Nardi, Felipe Noleto de Paiva, Queila Cristina Dias, Alexandra Pinheiro Fantinatti, and Wagner José Fávaro. 2023. "Clinical Implications of Immune Checkpoints and the RANK/RANK-L Signaling Pathway in High-Grade Canine Mast Cell Tumors" Animals 13, no. 12: 1888. https://doi.org/10.3390/ani13121888

Talavera Guillén, N. C., Barboza de Nardi, A., Noleto de Paiva, F., Dias, Q. C., Pinheiro Fantinatti, A., & Fávaro, W. J. (2023). Clinical Implications of Immune Checkpoints and the RANK/RANK-L Signaling Pathway in High-Grade Canine Mast Cell Tumors. Animals, 13(12), 1888. https://doi.org/10.3390/ani13121888